跳至主要内容
临床试验/NCT03740659
NCT03740659已完成2 期

Aqueous Humour Concentrations After Topical apPlication of combinEd Levofloxacin-dexamethasone Eye dRops and of Its Single Components: a randoMized, assEssor-blinded, Parallel-group Study in Patients Undergoing Cataract Surgery - iPERME

NTC srl2 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2018年9月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
NTC srl
入组人数
125
试验地点
2
主要终点
Aqueous Humour Concentration of Dexamethasone 21-phosphate

研究概览

简要总结

The purpose of this study is to evaluate the penetration of levofloxacin and dexamethasone 21-phosphate into the aqueous humour after ocular administration in combination or as single active ingredients.

详细描述

In most cases, postoperative care after cataract surgery consists of antiinflammatory and antibacterial drug therapy. The use of an ophthalmic solution containing the combination of a steroid and an antibiotic is routinely used in clinical practice; however, treatment duration could favour the emergence of antibiotic resistance. The study treatment associating a broad-spectrum antibiotic with a highly effective corticosteroid that can be used for a short period of time (one week) is therefore of considerable interest.

The aim of this study is to measure the concentrations of levofloxacin and dexamethasone in the aqueous humour after topical application of the combined ophthalmic solution and its single components.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

盲法说明

Single

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent
  • Male or female patients, aged ≥40 years
  • Patient undergoing phacoemulsification
  • Corneal thickness between 450 μm and 600 μm as measured by means of pachymetry
  • Corneal integrity confirmed by means of fluorescein test
  • Adequate pupil dilation assessed at screening
  • Female patients of childbearing potential must have a negative pregnancy test
  • Ability to fully understand all study procedures

排除标准

  • Corneal epithelium integrity not confirmed by fluorescein test
  • History of corneal disease or dystrophy
  • History of ocular trauma with corneal damage
  • History of acute ocular inflammation (including uveitis) in the 6 months prior to screening
  • Previous ocular surgery (including laser treatment)
  • Treatment with an ophthalmic investigational drug in the 3 months prior to screening
  • Treatment with any topical ocular drug within 12 hours before start of cataract surgery other than study drugs and instillation of topical anaesthetic within 10 minutes before start of surgery
  • Treatment with any topical steroid or antibiotic drug in the 7 days prior to cataract surgery
  • Treatment with any systemic steroid or antibiotic drug in the 7 days prior to cataract surgery
  • Known hypersensitivity to levofloxacin, other fluoroquinolones or dexamethasone
  • Pregnant or lactating women
  • Patients who have received any investigational drug during the preceding 30 days or 5 times the plasma half-life, or who have previously participated in this trial

研究组 & 干预措施

Levofloxacin + Dexamethasone

Experimental

Levofloxacin 5 mg/ml + Dexamethasone 1 mg/ml (30 μl administered twice before Limbal paracentesis).

Limbal paracentesis will be performed prior to cataract surgery.

干预措施: Levofloxacin + Dexamethasone (Drug)

Levofloxacin

Active Comparator

Levofloxacin 5 mg/ml (30 μl administered twice before Limbal paracentesis).

Limbal paracentesis will be performed prior to cataract surgery.

干预措施: Levofloxacin (Drug)

Dexamethasone

Active Comparator

Dexamethasone 1.14 mg/ml (26 μl administered twice before Limbal paracentesis).

Limbal paracentesis will be performed prior to cataract surgery.

干预措施: Dexamethasone (Drug)

结局指标

主要结局

Aqueous Humour Concentration of Dexamethasone 21-phosphate

时间窗: 90±15 min after the first administration of the study treatments

Defined as the concentration of dexamethasone 21-phosphate into the aqueous humour in all the three arms: Levofloxacin + Dexamethasone, Dexamethasone and Levofloxacin. The concentration of dexamethasone 21-phosphate has been measured by LC tandem mass spectrometry.

Aqueous Humour Concentration of Levofloxacin

时间窗: 90±15 min after the first administration of the study treatments

Defined as the concentration of levofloxacin into the aqueous humour in all the three arms: Levofloxacin + Dexamethasone, Dexamethasone and Levofloxacin.The concentration of levofloxacin has been measured by LC tandem mass spectrometry.

Aqueous Humour Concentration of Dexamethasone

时间窗: 90±15 min after the first administration of the study treatments

Defined as the concentration of dexamethasone into the aqueous humour in all the three arms: Levofloxacin + Dexamethasone, Dexamethasone and Levofloxacin.The concentration of dexamethasone has been measured by LC tandem mass spectrometry.

次要结局

未报告次要终点

研究者

发起方
NTC srl
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验